HOPE Therapeutics Secures Financing For Ketamine Clinic Expansion
Posted
Rolando García (via Benzinga)
HOPE Therapeutics, Inc., a subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), read more
Continue reading at Benzinga »
Keywords
Cannabis,
HOPE Therapeutics,
Ketamine Treatment,
News,
NPx Pharmaceuticals,
NRXP,
Penny Stocks,
Psychedelics,
Financing,
Markets,
NRXP,
News,
Penny Stocks,
Cannabis,
Psychedelics,
Financing,
Markets,
Benzinga
